Univariate analysis of prognostic factors for survival after BT
| Factor . | No. . | Median survival (95% CI) . | P . |
|---|---|---|---|
| Patient age, y | |||
| 50 or younger | 49 | 8.8 (7-10) | .04 |
| Older than 50 | 25 | 5.5 (4-7) | |
| WBC count at BT, × 109/L | |||
| No higher than 60 | 43 | 8.7 (5-12) | .04 |
| Higher than 60 | 19 | 5.6 (3-8) | |
| PB blasts at BT, % | |||
| No more than 50 | 35 | 8.2 (6-10) | .025 |
| More than 50 | 15 | 3.6 (0-7) | |
| Cytogenetic evolution | |||
| No | 24 | 11.8 (9-15) | .012 |
| Yes | 50 | 6.3 (5-7) | |
| Response to first/second therapy | |||
| CP | 34 | 13 (10-17) | .00001 |
| No CP | 40 | 5.7 (5-7) | |
| Pre-BT treatment | |||
| No more than 2 agents | 37 | 8.7 (6-11) | .05 |
| More than 2 agents | 35 | 6.8 (5-8) | |
| SCT | |||
| Yes | 37 | 11 (8-14) | .039 |
| No | 37 | 6.8 (5-8) | |
| Type of SCT | |||
| Allo | 23 | 11.6 (10.7-12.5) | .024 |
| Auto | 14 | 5.8 (3.5-8) |
| Factor . | No. . | Median survival (95% CI) . | P . |
|---|---|---|---|
| Patient age, y | |||
| 50 or younger | 49 | 8.8 (7-10) | .04 |
| Older than 50 | 25 | 5.5 (4-7) | |
| WBC count at BT, × 109/L | |||
| No higher than 60 | 43 | 8.7 (5-12) | .04 |
| Higher than 60 | 19 | 5.6 (3-8) | |
| PB blasts at BT, % | |||
| No more than 50 | 35 | 8.2 (6-10) | .025 |
| More than 50 | 15 | 3.6 (0-7) | |
| Cytogenetic evolution | |||
| No | 24 | 11.8 (9-15) | .012 |
| Yes | 50 | 6.3 (5-7) | |
| Response to first/second therapy | |||
| CP | 34 | 13 (10-17) | .00001 |
| No CP | 40 | 5.7 (5-7) | |
| Pre-BT treatment | |||
| No more than 2 agents | 37 | 8.7 (6-11) | .05 |
| More than 2 agents | 35 | 6.8 (5-8) | |
| SCT | |||
| Yes | 37 | 11 (8-14) | .039 |
| No | 37 | 6.8 (5-8) | |
| Type of SCT | |||
| Allo | 23 | 11.6 (10.7-12.5) | .024 |
| Auto | 14 | 5.8 (3.5-8) |